Journal article
Dose-escalated intensity modulated radiation therapy in patients with locally-advanced vulvar cancer - does it increase response rate?
Gynecologic oncology, v 159(3), pp 657-662
Dec 2020
PMID: 32981696
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
GOG 205 safely increased clinical (cCR) and pathologic complete response (pCR) in locally-advanced vulvar cancer through dose escalation using three-dimensional radiotherapy (RT). The aim of this study is to assess the response of dose-escalated intensity modulated radiotherapy (IMRT) in locally-advanced vulvar cancer.
A retrospective review of patients treated with dose-escalated (≥ 55Gy) IMRT from 2012 to 2018 for locally-advanced vulvar cancer was performed. Patients treated with preoperative or definitive intent were included. Rates of cCR and pCR were assessed, and predictors of disease-free survival (DFS) were analyzed using the Kaplan Meier method with log rank test between groups and a parsimonious multivariate Cox model.
Median dose to the vulva was 66.0 Gy (Interquartile Range [IQR]: 66.0–68.0) for definitive and 59.4 Gy (IQR: 58.0–59.4) for preoperative IMRT. The overall rates of cCR and pCR were 76% and 70%, respectively. DFS at two years was 65% (95% Confidence Interval [CI] 50–80%) for all patients, 81% (95% CI 63% - 98%) for definitive IMRT, and 55% (95% CI 35% - 76%) for preoperative IMRT. On multivariate analysis, cCR predicted for disease-free survival (HR 0.21; 95% CI 0.06–0.76; p = 0.02), and pCR predicted for OS (HR 0.12; 95% CI 0.02–0.60; p = 0.01). Grade 3 acute and late RT toxicity was seen in 14 (29%) and 3 (6%) of patients, respectively.
Dose-escalated IMRT for locally-advanced vulvar cancer is well tolerated, with rates of cCR and pCR that compare favorably with published data.
•Median dose to the vulva was 66.0 Gy for definitive and 59.4 Gy for preoperative IMRT.•The rates of cCR and pCR were 48% and 31% in GOG 101, 64% and 50% in GOG 205, and 76% and 70% in the present study.•Patients node negative on imaging received 45–50 Gy to the groin without biopsy.•No isolated inguinal failures were observed in patients that were node negative on imaging.•On multivariate analysis, cCR predicted for disease-free survival and pCR predicted for OS.
Metrics
Details
- Title
- Dose-escalated intensity modulated radiation therapy in patients with locally-advanced vulvar cancer - does it increase response rate?
- Creators
- Adam H. Richman - UPMC Hillman Cancer CenterJohn A. Vargo - UPMC Hillman Cancer CenterDiane C. Ling - UPMC Hillman Cancer CenterPaniti Sukumvanich - University of Pittsburgh Medical CenterJessica L. Berger - Magee-Womens HospitalMichelle M. Boisen - Magee-Womens HospitalRobert Edwards - Magee-Womens HospitalSarah E. Taylor - Magee-Womens HospitalMadeleine B. Courtney-Brooks - University of Pittsburgh Medical CenterAlexander Olawaiye - Magee-Womens HospitalBrian C. Orr - Magee-Womens HospitalSushil Beriwal - UPMC Hillman Cancer Center
- Publication Details
- Gynecologic oncology, v 159(3), pp 657-662
- Publisher
- Elsevier
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Radiation Oncology (and Nuclear Medicine)
- Web of Science ID
- WOS:000596721200012
- Scopus ID
- 2-s2.0-85091521127
- Other Identifier
- 991021897289204721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Obstetrics & Gynecology
- Oncology